{"title":"Formalin Hazards and Health Insurance Coverage Needs among Exposed Personnel","authors":"Ocimum Scientific Publishers Pty Ltd","doi":"10.33513/RABS/1901-03","DOIUrl":"https://doi.org/10.33513/RABS/1901-03","url":null,"abstract":"Formaldehyde is a colorless, strong-smelling gas often found in aqueous (water based) solutions and commonly used as a preservative in medical laboratories and mortuaries or an industrial fungicide, germicide and disinfectant. The WHO in its 2019 health report has classified Formalin as a potential carcinogen and an occupational hazard. The more concentrated overexposure is paradoxically related to the medical and lab technology field. Its use has been eliminated in most high-income country facilities owing to the well-known teratogenic effects; however, in facilities of many middle- and low-income countries, it is still used freely. The safety protocols requiring regular monitoring of formalin air level concentrations under permissible levels are often ignored; owing to logistics, staff crisis, lack of obserwership by management and key stake holders, lack of awareness or sometimes, plain carelessness and underestimation of immediate risks. Short term symptoms of exposure are mainly respiratory, nasopharyngeal, ocular and/or dermal irritation. But the long term more grave effects include permanent metaplastic changes majorly in nasopharynx, oropharynx leading to nasal or lung cancers. While health care is entering the era of big data, insurance companies still remain in the dark when it comes to Formaldehyde perils. This is alarming and calls for not only developing safe working protocols but also increased awareness of the need for “safety coverage umbrellas” under health insurance schemes (considering Formalin being a potential occupational hazard that can hamper not only the life quality of the exposed health care / medical lab personnel; but also lead to significant morbidity and death). This paper elucidates the gravity of formalin usage, need for awareness about its associated risks, safety protocols and health insurance coverage for personnel exposed to such occupational hazards.","PeriodicalId":147833,"journal":{"name":"Research and Advances: Biomedical Science and Technology","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116355142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intracranial Aneurysms: Evaluation of Braid Pore Configurations on Flow Disruption with Flow Diverter Devices","authors":"Sreenivas Venguru, Kevin Nguyen, Jim, Davidson","doi":"10.33513/rabs/1901-02","DOIUrl":"https://doi.org/10.33513/rabs/1901-02","url":null,"abstract":"Flow diverters have recently been developed to treat intracranial aneurysms as an alternative to standard coiling. The Medtronic PipelineTM flow diverter stent device had a positive impact on aneurysm repair in the past few years and is the leading braided Flow Diverter (FD) in the market. The main function of the flow diverter is to alter the hemodynamics within the aneurysm so that flow circulation is reduced to allow for gradual thrombosis within the aneurysm and subsequent healing. Thus, it is highly desirable to better understand the hemodynamic parameters and flow diverter efficacy. The objective of the study is to assess the hemodynamic impact of braided flow diverter, pore configuration parameters as related to flow circulation. Appropriate Computer Aided Design (CAD) and Computational Fluid Dynamic (CFD) models of an aneurysm, with and without presence of a Flow Diverter, were evaluated. Transient CFD analysis (Pulsatile flow) was performed with appropriate boundary conditions. Using CFD, the parameters that influence the flow into the aneurysm are evaluated and discussed.","PeriodicalId":147833,"journal":{"name":"Research and Advances: Biomedical Science and Technology","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121597135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Three-Dimensional (3D) Imaging Spectroscopy of Carcinoma, Sarcoma, Leukemia, Lymphoma, Multiple Myeloma, Melanoma, Brain and Spinal Cord Tumors, Germ Cell Tumors, Neuroendocrine Tumors and Carcinoid Tumors under Synchrocyclotron Radiation","authors":"A. Heidari","doi":"10.33513/rabs/1801-01","DOIUrl":"https://doi.org/10.33513/rabs/1801-01","url":null,"abstract":"In the current study, we respectively present Three-dimensional (3D) imaging spectroscopy of carcinoma, sarcoma, leukemia, lymphoma, multiple myeloma, melanoma, brain and spinal cord tumors, germ cell tumors, neuroendocrine tumors and carcinoid tumors under synchrocyclotron radiation [1-223]. In fact, in the current research, first, we have experimentally presented therapeutic Nano medicine different high-resolution experimental images for carcinoma, sarcoma,","PeriodicalId":147833,"journal":{"name":"Research and Advances: Biomedical Science and Technology","volume":"132 20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127429598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}